PET scan using a new imaging agent for Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This study tests a new PET imaging agent called [18F]F-AraG to see if it can help spot changes in the brain linked to Alzheimer's disease. The trial is for people who may have Alzheimer's and uses a special scan to look for signs of inflammation or other immune activity in the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 55 years old or older
- You need to have had an MRI scan of your brain, or be willing to have a new one
- You must have a diagnosis of possible or probable Alzheimer's disease (based on standard criteria)
- You must be able to lie still for a PET scan and follow study procedures
- You need a study partner (like a family member or friend) who can answer questions about your daily activities
- If you are able to have children, you must agree to use effective contraception while in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to create a simulated FDG PET brain scan from an amyloid PET scan. This could help doctors monitor Alzheimer's disease without needing an extra scan, making diagnosis and tracking easier.
This study uses special PET brain scans to look at proteins linked to Alzheimer's disease, which may help diagnose it and track how it changes over time.
This trial uses a new type of PET scan to look for specific proteins in the brain that are linked to Alzheimer's disease. It will help doctors see how these proteins relate to cognitive decline and compare scans from people with normal thinking to those with memory problems.
This trial uses special PET scans to see amyloid and tau proteins in the brain, which are linked to Alzheimer's. It aims to find these changes early, in people with mild memory problems or early-stage Alzheimer's.
This study uses a special PET scan to look at a brain protein called PDE4 in people with Alzheimer's disease or mild cognitive impairment. It may help researchers understand how this protein is involved in memory and thinking problems.
This study uses a PET brain scan with a small injected tracer to look for “tau” protein changes linked to Alzheimer’s disease. It may help researchers better understand how tau appears in people who are cognitively normal or have mild dementia.
Hear when a new Alzheimer Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.